115
Views
5
CrossRef citations to date
0
Altmetric
Review

Is there evidence that we should screen the general population for Lynch syndrome with genetic testing? A systematic review

, , , , , , , , & show all
Pages 49-60 | Published online: 20 Feb 2017

References

  • EvansJPBergJSOlshanAFMagnusonTRimerBKWe screen newborns, don’t we?: realizing the promise of public health genomicsGenet Med201315533233423470837
  • GuttmacherAECollinsFSKhouryMJMcCabeLLMcCabeERPopulation screening in the age of genomic medicineN Engl J Med20033481505812510043
  • Levy-LahadELahadAKingMCPrecision medicine meets public health: population screening for BRCA1 and BRCA2J Natl Cancer Inst2015107142025550384
  • Million Veteran Program (MVP) Available from: http://www.research.va.gov/mvp/Accessed November 11, 2015
  • The 100,000 Genomes Project Available from: http://www.genomic-sengland.co.uk/about-genomics-england/Accessed November 4, 2015
  • RayTCompanies Begin Subsidizing Color Genomics’ Breast, Ovarian Cancer Testing for EmployeesGenomeWeb2015 Available from: https://www.genomeweb.com/molecular-diagnostics/companies-begin-subsidizing-color-genomics-breast-ovarian-cancer-testingAccessed December 2, 2016
  • HelgerMGeisinger Begins Returning Clinically Actionable Exome Sequencing Results to PatientsGenomeWeb2015
  • KohlmannWGruberSBLynch syndromePagonRAAdamMPArdingerHHGeneReviews®Seattle, WAUniversity of Washington1993
  • ChenSWangWLeeSPrediction of germline mutations and cancer risk in the Lynch syndromeJAMA2006296121479148717003396
  • LindorNMPetersenGMHadleyDWRecommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic reviewJAMA2006296121507151717003399
  • VasenHFBlancoIAktan-CollanKRevised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European expertsGut201362681282323408351
  • Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relativesGenet Med2009111354119125126
  • MoyerVARisk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: US Preventive Services Task Force recommendation statementAnn Intern Med2014160427128124366376
  • US Preventive Services Task Force Procedure Manual Available from: https://www.uspreventiveservicestaskforce.org/Page/Name/methods-and-processes?Accessed December 2, 2016
  • PalomakiGEMcClainMRMelilloSHampelHLThibodeauSNEGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndromeGenet Med2009111426519125127
  • Agency for Healthcare Research and QualityMethods Guide for Effectiveness and Comparative Effectiveness ReviewsRockville, MDAgency for Healthcare Research and Quality2014
  • ViswanathanMAnsariMTBerkmanNDAssessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care InterventionsRockville, MDAHRQ Publication No. 12-EHC047-EF2012
  • Agency for Healthcare Research and QualityMethods Guide for Medical Test ReviewsRockville, MDAgency for Healthcare Research and Quality2012
  • WhitingPFRutjesAWWestwoodMEQUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studiesAnn Intern Med2011155852953622007046
  • SuttonAJAbramsKRJonesDRMethods for Meta-Analysis in Medical Research (Wiley Series in Probability and Statistics – Applied Probability and Statistics Section)London, UKWiley2000
  • HigginsJPThompsonSGQuantifying heterogeneity in a meta-analysisStat Med200221111539155812111919
  • HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455712958120
  • OwensDKLohrKNAtkinsDAHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions – Agency for Healthcare Research and Quality and the Effective Health-Care ProgramJ Clin Epidemiol201063551352319595577
  • BerkmanNDLohrKNAnsariMTGrading the strength of a body of evidence when assessing health care interventions: an EPC updateJ Clin Epidemiol201468111312132425721570
  • DinhTARosnerBIAtwoodJCHealth benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general populationCancer Prev Res (Phila)20114192221088223
  • HansenMFNeckmannULavikLAA massive parallel sequencing workflow for diagnostic genetic testing of mismatch repair genesMol Genet Gen Med201422186200
  • PritchardCCSmithCSalipanteSJColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencingJ Mol Diagn201214435736622658618
  • StucklessSGreenJSMorgensternMImpact of colonoscopic screening in male and female Lynch syndrome carriers with an MSH2 mutationClin Gen2012825439445
  • StupartDAGoldbergPAAlgarURamesarRSurveillance colonoscopy improves survival in a cohort of subjects with a single mismatch repair gene mutationColorectal Dis200911212613019143775
  • JarvinenHJAarnioMMustonenHControlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancerGastroenterology2000118582983410784581
  • SchmelerKMLynchHTChenLMProphylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndromeN Engl J Med2006354326126916421367
  • StucklessSGreenJDawsonLImpact of gynecological screening in Lynch syndrome carriers with an MSH2 mutationClin Gen2013834359364
  • Renkonen-SinisaloLButzowRLeminenALehtovirtaPMecklinJPJarvinenHJSurveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndromeInt J Cancer2007120482182417096354
  • BrehenyNGeelhoedEGoldblattJEeHO’LearyPEconomic evaluation of the familial cancer programme in Western Australia: predictive genetic testing for familial adenomatous polyposis and hereditary non-polyposis colorectal carcinomaCommunity Genet2006929810616612060
  • YangKYCaugheyABLittleSECheungMKChenLMA cost-effectiveness analysis of prophylactic surgery versus gynecologic surveillance for women from hereditary non-polyposis colorectal cancer (HNPCC) familiesFam Cancer201110353554321538078
  • VasenHFvan BallegooijenMBuskensEA cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriersCancer1998829163216379576281
  • KastrinosFSteyerbergEWMercadoRThe PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer historyGastroenterology20111401738120727894
  • KocarnikJMFullertonSMReturning pleiotropic results from genetic testing to patients and research participantsJAMA2014311879579624481117
  • PrinceAEBergJSEvansJPJonasDEHendersonGGenomic screening of the general adult population: key concepts for assessing net benefit with systematic evidence reviewsGenet Med201517644144325232850
  • AdamsMCEvansJPHendersonGEBergJSInvestigatorsGThe promise and peril of genomic screening in the general populationGenet Med201618659359926540154
  • WhitlockEPLinJSLilesEBeilTLFuRScreening for colorectal cancer: a targeted, updated systematic review for the US Preventive Services Task ForceAnn Intern Med2008149963865818838718
  • BleikerEMEsplenMJMeiserBPetersenHVPatenaudeAF100 years Lynch syndrome: what have we learned about psychosocial issues?Fam Cancer201312232533923670341
  • SieASPrinsJBSpruijtLKetsCMHoogerbruggeNCan we test for hereditary cancer at 18 years when we start surveillance at 25? Patient reported outcomesFam Cancer201312467568223604858
  • CollinsVRMeiserBUkoumunneOCGaffCSt JohnDJHallidayJLThe impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: three years after testingGenet Med20079529029717505206